We want to thank you very much.
We'll now move on to the University of Toronto. We have with us, by video conference, Dr. Janis Miyasaki, associate clinical director and the of the technology and therapeutics assessment subcommittee of the American Academy of Neurology.
The floor is yours and you have ten minutes. We look forward to your presentation.